{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:26:58Z","timestamp":1782808018822,"version":"3.54.5"},"reference-count":20,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":956,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes (NHRI)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jfda.2013.09.040","type":"journal-article","created":{"date-parts":[[2013,10,26]],"date-time":"2013-10-26T18:45:37Z","timestamp":1382813137000},"page":"S82-S86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S","title":["Treatment of methamphetamine abuse: An antibody-based immunotherapy approach"],"prefix":"10.38212","volume":"21","author":[{"given":"Yun-Hsiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Lun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Min","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2013.09.040_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11904-005-0016-4","article-title":"The methamphetamine epidemic: implications for HIV prevention and treatment","volume":"2","author":"Colfax","year":"2005","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jfda.2013.09.040_bib2","first-page":"301","article-title":"The need for speed: an update on methamphetamine addiction","volume":"31","author":"Barr","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.jfda.2013.09.040_bib3","first-page":"214","article-title":"Methamphetamine and the expanding complications of amphetamines","volume":"170","author":"Albertson","year":"1999","journal-title":"West J Med"},{"key":"10.1016\/j.jfda.2013.09.040_bib4","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1086\/379894","article-title":"Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy","volume":"188","author":"Ellis","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfda.2013.09.040_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsat.2006.04.006","article-title":"Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment","volume":"31","author":"Gonzales","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.jfda.2013.09.040_bib6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2125.2010.03639.x","article-title":"Pharmacological approaches to methamphetamine dependence: a focused review","volume":"69","author":"Karila","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.jfda.2013.09.040_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1360-0443.2007.01772.x","article-title":"Approaches to the development of medications for the treatment of methamphetamine dependence","volume":"102","author":"Vocci","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jfda.2013.09.040_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4161\/hv.5.4.7456","article-title":"Development of active and passive human vaccines to treat methamphetamine addiction","volume":"5","author":"Gentry","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jfda.2013.09.040_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/icb.2009.17","article-title":"Anti-drug vaccines to treat substance abuse","volume":"87","author":"Kinsey","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jfda.2013.09.040_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.jfda.2013.09.040_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/156652313804806552","article-title":"The development of antibody-based immunotherapy for methamphetamine abuse: immunization, and virus-mediated gene transfer approaches","volume":"13","author":"Chen","year":"2013","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jfda.2013.09.040_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jfda.2013.09.040_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.106.117150","article-title":"Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse","volume":"322","author":"Peterson","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfda.2013.09.040_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2005.08.016","article-title":"Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats","volume":"521","author":"Byrnes-Blake","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jfda.2013.09.040_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1567-5769(00)00019-9","article-title":"Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats","volume":"1","author":"Byrnes-Blake","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jfda.2013.09.040_bib16","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","article-title":"A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity","volume":"35","author":"Maurer","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jfda.2013.09.040_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1359-6446(05)03638-X","article-title":"Elimination mechanisms of therapeutic monoclonal antibodies","volume":"11","author":"Tabrizi","year":"2006","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jfda.2013.09.040_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/hum.2005.16.541","article-title":"Adeno-associated virus vectors in clinical trials","volume":"16","author":"Carter","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jfda.2013.09.040_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/156652310791111047","article-title":"Effect of administration route on the biodistribution and shedding of replication-deficient AAV2: a qualitative modelling approach","volume":"10","author":"Brandon","year":"2010","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.jfda.2013.09.040_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nbt1087","article-title":"Stable antibody expression at therapeutic levels using the 2A peptide","volume":"23","author":"Fang","year":"2005","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981300104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981300104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S102194981300104X?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:16:03Z","timestamp":1666635363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S102194981300104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S102194981300104X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2013.09.040","relation":{},"ISSN":["1021-9498"],"issn-type":[{"value":"1021-9498","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of methamphetamine abuse: An antibody-based immunotherapy approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2013.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}